Fredrik Erlandsson
Chief Medical Officer Purespring Therapeutics
Seminars
Thursday 18th March 2027
Clinical Development of AAV Based Gene Therapies for Glomerular Diseases
11:30 am
- Expected side effects of AAV-based gene therapies, and mitigation strategies
- Operationalizing gene therapies in nephrology
- Current and coming clinical gene therapies targeting glomerular diseases